Novo Nordisk A/s logo

Novo Nordisk A/s share price today

(NVO)

Novo Nordisk A/s share price is $87.37 & ₹7,443.75 as on 25 Dec 2024, 2.30 'hrs' IST

$87.37

-1.34

(-1.51%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Novo Nordisk A/s share price in Dollar and Rupees. Guide to invest in Novo Nordisk A/s from India. Also see the sentimental analysis on Indian investors investing in Novo Nordisk A/s. Get details on the Indian mutual funds that are investing in Novo Nordisk A/s. Get Analyst recommendations and forecasts along with all the Novo Nordisk A/s's financials.

Novo Nordisk A/s share price movements

  • Today's Low: $87.13
    Today's High: $88.53

    Day's Volatility :1.59%

  • 52 Weeks Low: $81.50
    52 Weeks High: $148.15

    52 Weeks Volatility :44.99%

Novo Nordisk A/s Returns

PeriodNovo Nordisk A/sSector (Health Care)Index (Russel 2000)
3 Months
-29.71%
-9.0%
0.0%
6 Months
-39.53%
-4.6%
0.0%
1 Year
-15.73%
3.0%
0.0%
3 Years
56.53%
0.0%
-21.1%

Novo Nordisk A/s Key Statistics

in dollars & INR

Previous Close
$88.71
Open
$88.9
Today's High
$88.53
Today's Low
$87.125
Market Capitalization
$363.6B
Today's Volume
$4.8M
52 Week High
$148.15
52 Week Low
$81.5
Revenue TTM
$270.6B
EBITDA
$127.4B
Earnings Per Share (EPS)
$2.95
PE Ratio
30.07
Dividend Yield
1.7%
Profit Margin
35.01%
Quarterly Earnings Growth YOY
0.22%
Return On Equity TTM
88.73%

How to invest in Novo Nordisk A/s from India?

It is very easy for Indian residents to invest directly in Novo Nordisk A/s from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Novo Nordisk A/s stock in both Indian Rupees (INR) and US Dollars (USD). Search for Novo Nordisk A/s or NVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Novo Nordisk A/s or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Novo Nordisk A/s shares which would translate to 0.010 fractional shares of Novo Nordisk A/s as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Novo Nordisk A/s, in just a few clicks!

Returns in Novo Nordisk A/s for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Novo Nordisk A/s investment value today

Current value as on today

₹86,508

Returns

₹13,492

(-13.49%)

Returns from Novo Nordisk A/s Stock

₹15,731 (-15.73%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Novo Nordisk A/s

63.29%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Novo Nordisk A/s from India has grown in the last 30 days as on Dec 26, 2024. 63.29% more purchase transactions for Novo Nordisk A/s in the last 30 days versus the previous period.

75%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Novo Nordisk A/s on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 75% more investors are searching Novo Nordisk A/s in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Novo Nordisk A/s

NameShares HeldChange in Shares% of Assets
Axis Innovation Fund Direct Growth
8068
-440.27
0.59%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
4514
-2021.73
2.71%

Global Institutional Holdings in Novo Nordisk A/s

  • Jennison Associates LLC

    0.45%

  • FMR Inc

    0.40%

  • Morgan Stanley - Brokerage Accounts

    0.32%

  • Bank of America Corp

    0.32%

  • Fisher Asset Management, LLC

    0.30%

  • Fayez Sarofim & Company

    0.28%

Analyst Recommendation on Novo Nordisk A/s

Buy

    62%Buy

    31%Hold

    6%Sell

Based on 32 Wall street analysts offering stock ratings for Novo Nordisk A/s(by analysts ranked 0 to 5 stars)

Based on 32 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
20
20
18
Hold
10
10
10
Sell
2
1
3

Analyst Forecast on Novo Nordisk A/s

What analysts predicted

Upside of 39.37%

Current:

$87.37

Target:

$121.77

Insights on Novo Nordisk A/s

  • Price Movement

    In the last 7 days, NVO stock has moved down by -15.5%
  • Increasing Revenue

    Novo Nordisk A/S has shown consistent revenue growth over the last three quarters. The company's revenue increased from $65.34 billion to $71.31 billion, representing an average growth of 4.3% each quarter.
  • Increasing Net Profit

    Novo Nordisk A/s has shown consistent profit growth over the last two quarters. Their net profit increased from $20.05 billion to $27.30 billion, marking an average rise of 26.6% per quarter.
  • NVO vs LLY (1 yr)

    In the last 1 year, Eli Lilly And Company has given 39.4% return, outperforming this stock by 54.3%
  • NVO vs LLY (3 yr)

    In the last 3 years, Eli Lilly And Company has given 191.3% return, outperforming this stock by 130.1%
  • Price to Sales

    Novo Nordisk A/S has a Price-to-Sales Ratio of 1.4, which means investors are willing to pay $1.40 for every $1 of sales. In comparison, investors are willing to pay significantly more for Eli Lilly And Company, at $17.50 for every $1 of sales. This suggests that Novo Nordisk is currently valued lower in terms of sales compared to Eli Lilly.

Novo Nordisk A/s Financials in INR & Dollars

FY18Y/Y Change
Revenue
$17.0B
↑ 0.12%
Net Income
$5.9B
↑ 1.31%
Net Profit Margin
34.54%
↑ 0.4%
FY19Y/Y Change
Revenue
$18.1B
↑ 9.11%
Net Income
$5.8B
↑ 0.84%
Net Profit Margin
31.92%
↓ 2.62%
FY20Y/Y Change
Revenue
$20.7B
↑ 4.04%
Net Income
$6.9B
↑ 8.18%
Net Profit Margin
33.19%
↑ 1.27%
FY21Y/Y Change
Revenue
$21.4B
↑ 10.91%
Net Income
$7.3B
↑ 13.33%
Net Profit Margin
33.92%
↑ 0.73%
FY22Y/Y Change
Revenue
$25.2B
↑ 25.68%
Net Income
$7.9B
↑ 16.27%
Net Profit Margin
31.38%
↓ 2.54%
FY23Y/Y Change
Revenue
$34.0B
↑ 31.26%
Net Income
$12.3B
↑ 50.71%
Net Profit Margin
36.03%
↑ 4.65%
Q2 FY23Q/Q Change
Revenue
$7.9B
↑ 1.75%
Net Income
$2.8B
↓ 1.95%
Net Profit Margin
35.78%
↓ 1.35%
Q3 FY23Q/Q Change
Revenue
$8.4B
↑ 8.16%
Net Income
$3.2B
↑ 15.7%
Net Profit Margin
38.27%
↑ 2.49%
Q4 FY23Q/Q Change
Revenue
$9.6B
↑ 12.14%
Net Income
$3.2B
↓ 2.29%
Net Profit Margin
33.35%
↓ 4.92%
Q1 FY24Q/Q Change
Revenue
$9.5B
↓ 0.78%
Net Income
$3.7B
↑ 15.68%
Net Profit Margin
38.88%
↑ 5.53%
Q2 FY24Q/Q Change
Revenue
$9.8B
↑ 4.15%
Net Income
$2.9B
↓ 21.08%
Net Profit Margin
29.46%
↓ 9.42%
Q3 FY24Q/Q Change
Revenue
$71.3B
↑ 4.78%
Net Income
$27.3B
↑ 36.16%
Net Profit Margin
38.28%
↑ 8.82%
FY18Y/Y Change
Profit
$14.4B
↑ 0.16%
FY19Y/Y Change
Profit
$15.2B
↑ 8.19%
FY20Y/Y Change
Profit
$17.3B
↑ 4.0%
FY21Y/Y Change
Profit
$17.8B
↑ 10.5%
FY22Y/Y Change
Profit
$21.1B
↑ 26.77%
FY23Y/Y Change
Profit
$28.8B
↑ 32.32%
Q2 FY23Q/Q Change
Profit
$6.8B
↑ 2.79%
Q3 FY23Q/Q Change
Profit
$7.0B
↑ 5.54%
Q4 FY23Q/Q Change
Profit
$8.2B
↑ 13.94%
Q1 FY24Q/Q Change
Profit
$8.1B
↓ 0.74%
Q2 FY24Q/Q Change
Profit
$8.3B
↑ 4.24%
Q3 FY24Q/Q Change
Profit
$60.0B
↑ 3.84%
FY18Y/Y Change
Operating Cash Flow
$6.8B
↑ 8.38%
Investing Cash Flow
$-1.8B
↑ 83.84%
Financing Cash Flow
$-5.3B
↓ 3.27%
FY19Y/Y Change
Operating Cash Flow
$7.0B
↑ 4.85%
Investing Cash Flow
$-1.7B
↓ 4.73%
Financing Cash Flow
$-5.3B
↑ 2.79%
FY20Y/Y Change
Operating Cash Flow
$8.5B
↑ 11.05%
Investing Cash Flow
$-3.7B
↑ 94.94%
Financing Cash Flow
$-5.3B
↓ 9.13%
FY21Y/Y Change
Operating Cash Flow
$8.4B
↑ 5.87%
Investing Cash Flow
$-4.8B
↑ 40.87%
Financing Cash Flow
$-3.9B
↓ 20.94%
FY22Y/Y Change
Operating Cash Flow
$11.2B
↑ 43.43%
Investing Cash Flow
$-3.5B
↓ 21.16%
Financing Cash Flow
$-7.4B
↑ 103.18%
Q2 FY23Q/Q Change
Operating Cash Flow
$4.2B
↓ 4.15%
Investing Cash Flow
$-2.3B
↑ 139.69%
Financing Cash Flow
$-1.8B
↓ 38.95%
Q3 FY23Q/Q Change
Operating Cash Flow
$5.9B
↑ 43.35%
Investing Cash Flow
$-4.2B
↑ 83.12%
Financing Cash Flow
$-2.8B
↑ 57.53%

Novo Nordisk A/s Technicals Summary

Sell

Neutral

Buy

Novo Nordisk A/s is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Novo Nordisk A/s Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Novo Nordisk A/s
-17.68%
-39.53%
-15.73%
56.53%
202.68%
Eli Lilly And Company
0.8%
-12.47%
36.83%
185.79%
505.99%
Johnson & Johnson
-5.61%
0.03%
-6.72%
-14.04%
0.38%
Merck & Co. Inc.
-2.14%
-23.39%
-7.9%
29.88%
9.25%
Abbvie Inc
-0.63%
6.52%
16.22%
33.92%
103.34%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Novo Nordisk A/s
30.07
30.07
1.34
22.83
0.89
0.21
0.02
27.07
Eli Lilly And Company
85.44
85.44
0.72
13.14
0.65
0.14
0.01
15.83
Johnson & Johnson
24.05
24.05
0.87
9.96
0.21
0.08
0.03
29.14
Merck & Co. Inc.
20.79
20.79
0.07
7.74
0.28
0.11
0.03
17.58
Abbvie Inc
62.16
62.16
0.43
10.94
0.56
0.08
0.04
3.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Novo Nordisk A/s
Buy
$363.6B
202.68%
30.07
35.01%
Eli Lilly And Company
Buy
$716.1B
505.99%
85.44
20.48%
Johnson & Johnson
Buy
$349.8B
0.38%
24.05
16.74%
Merck & Co. Inc.
Buy
$251.4B
9.25%
20.79
19.23%
Abbvie Inc
Buy
$315.2B
103.34%
62.16
9.22%

Novo Nordisk A/s Dividend announcements

  • Novo Nordisk A/s Dividends September, 2024

    In the quarter ending September,2024. Novo Nordisk A/s has declared dividend of $0.51

    Read More

About Novo Nordisk A/s

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
Organization
Novo Nordisk A/s
Employees
71880
CEO
Mr. Lars Fruergaard Jorgensen
Industry
Health Technology

Management People of Novo Nordisk A/s

NameTitle
Mr. Lars Fruergaard Jorgensen
President, CEO & Member of Management Board
Mr. Karsten Munk Knudsen
Executive VP, CFO & Member of the Management Board
Mr. Henrik Ehlers Wulff
Executive VP of Product Supply, Quality & IT and Member of the Management Board
Ms. Camilla Sylvest
Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board
Dr. Martin Holst Lange
Executive VP of Development & Member of the Management Board
Dr. Marcus Schindler Ph.D.
EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board
Mr. Maziar Mike Doustdar
Executive VP of International Operations & Member of the Management Board
Mr. Douglas J. Langa
Executive VP of North America Operations & Member of Management Board
Mr. Ludovic Helfgott
Executive VP, Head of Rare Disease & Member of Management Board
Ms. Tania Sabroe
Executive VP of Global People & Organisation and Member of Management Board

Important FAQs about investing in Novo Nordisk A/s from India :

What is Novo Nordisk A/s share price today?

Novo Nordisk A/s share price today stands at $87.37, Open: $88.90 ; Previous Close: $88.71 ; High: $88.53 ; Low: $87.13 ; 52 Week High: $148.15 ; 52 Week Low: $81.50. The stock opens at $88.90, after a previous close of $88.71. The stock reached a daily high of $88.53 and a low of $87.13, with a 52-week high of $148.15 and a 52-week low of $81.50.

Can Indians buy Novo Nordisk A/s shares?

Yes, Indians can invest in the Novo Nordisk A/s (NVO) from India.

With INDmoney, you can buy Novo Nordisk A/s at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Novo Nordisk A/s at zero transaction cost.

How can I buy Novo Nordisk A/s shares from India?

It is very easy to buy Novo Nordisk A/s from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Novo Nordisk A/s be purchased?

Yes, you can buy fractional shares of Novo Nordisk A/s with INDmoney app.

What are the documents required to start investing in Novo Nordisk A/s stocks?

To start investing in Novo Nordisk A/s, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Novo Nordisk A/s

Today’s highest price of Novo Nordisk A/s (NVO) is $88.53.

Today’s lowest price of Novo Nordisk A/s (NVO) is $87.13.

What is today's market capitalisation of Novo Nordisk A/s

Today's market capitalisation of Novo Nordisk A/s NVO is 363.6B

What is the 52 Week High and Low Range of Novo Nordisk A/s

  • 52 Week High

    $148.15

  • 52 Week Low

    $81.50

What are the historical returns of Novo Nordisk A/s?

  • 1 Month Returns

    -17.68%

  • 3 Months Returns

    -39.53%

  • 1 Year Returns

    -15.73%

  • 5 Years Returns

    202.68%

Who is the Chief Executive Officer (CEO) of Novo Nordisk A/s

Mr. Lars Fruergaard Jorgensen is the current Chief Executive Officer (CEO) of Novo Nordisk A/s.